Quarter Period Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7549480

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Quarter period consolidated statement of income
Statement of income
Net sales
16,000 JPY
106,000 JPY
Cost of sales
4,000 JPY
26,000 JPY
Gross profit (loss)
12,000 JPY
79,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
293,447,000 JPY
545,503,000 JPY
Operating profit (loss)
-293,435,000 JPY
-545,423,000 JPY
Non-operating income
Non-operating income
186,000 JPY
308,000 JPY
Non-operating expenses
Non-operating expenses
626,000 JPY
3,106,000 JPY
Ordinary profit (loss)
-293,875,000 JPY
-548,221,000 JPY
Extraordinary losses
Impairment losses
1,406,000 JPY
JPY
Extraordinary losses
1,406,000 JPY
JPY
Profit (loss) before income taxes
-295,281,000 JPY
-548,221,000 JPY
Income taxes - current
475,000 JPY
475,000 JPY
Income taxes
475,000 JPY
475,000 JPY
Profit (loss)
-295,756,000 JPY
-548,696,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.